DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Zydus Lifesciences Limited — Acquisition of 'to be incorporated companies'-XBRL

NSE 4d ago·26 Aug 2026, 8:24 am

Zydus Lifesciences

Zydus Lifesciences has announced plans to acquire entities that are currently in the process of being incorporated. This strategic move involves purchasing the shares of these newly forming companies, which will likely be integrated into Zydus's existing business operations. The company has filed the necessary regulatory documents with the stock exchanges to disclose this proposed transaction.

For investors, this development signals Zydus's intent to expand its portfolio through new ventures. Such acquisitions often aim to diversify the company's product range or enter new therapeutic segments. While the specific details of the target companies remain undisclosed at this stage, the move reflects the firm's strategy for future growth and market expansion.

Investors should monitor the official announcements for further details regarding the valuation and the specific sectors these new companies will operate in. Keeping an eye on the company's future quarterly reports will provide clarity on how these new entities contribute to the overall business performance.